AnandRathi

Syngene International Ltd Share Price

Last Updated Date: 16 Sept 2026
380.15
+2.00 (+0.53%)

As of 17 Sept 2026, Syngene International Ltd share price is ₹380.15. The stock opened at ₹380.15 and had closed at ₹378.15 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹374.75 and a high of ₹678.00. In terms of performance, Syngene International Ltd share price has decreased by 9.38% over the past six months and has decreased by 42.26% over the last year.

SYNGENE Stock Price Chart

Syngene International Ltd Overview

Market cap₹15,345 Crs
Volume19,709
Prev. Close₹378.15
Year range₹374.75 - ₹678.00
ISININE398R01022

About SYNGENE

Syngene International is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Syngene’s services include integrated drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services.

Syngene International Ltd Historical Performance

1 Month Return-5.73%
6 Month Return-7.35%
3 Year Return-54.42%
3 Month Return-16.16%
1 Year Return-42.14%
5 Year Return-41.27%

Syngene International Ltd Fundamentals

ROCE(TTM)9.60%
P/E Ratio (TTM)67.05
P/B Ratio3.26
Debt to Equity0.04
ROE7.68%
EPS (TTM)7.43
Dividend Yield0.33%
Book Value116.55
Profit Margin9.13%
Operating Margin10.24%

Syngene International Ltd Financials

IndicatorMar 26Mar 25Mar 24Mar 23Mar 22
Revenue3,490.703,443.803,291.103,264.402,654.20
EBITDA808.301,020.10955.701,005.20815.50
Net Profit304.90468.00466.50473.00393.80
EPS7.5811.6411.6211.819.89

Syngene International Ltd Technical Analysis

IndicatorValue
Support 1 (S1)375.43
Resistance 1 (R1)382.83
Pivot Point380.12

Syngene International Ltd Dividend History

Ex DateDividends DateRecord DateDividend TypeDividend Details
25-Jun-202629-Apr-202626-Jun-2026Final₹1.25
27-Jun-202523-Apr-202527-Jun-2025Final₹1.25
28-Jun-202424-Apr-202428-Jun-2024Final₹1.25
30-Jun-202326-Apr-202330-Jun-2023Final₹0.50
30-Jun-202326-Apr-202330-Jun-2023Special₹0.75

SYNGENE Latest Shareholding

  • Promoters Holding (52.59%)
  • FIIs Holding (-13.96%)
  • DIIs Holding (28.02%)
  • Public Holding (6.14%)
  • Mutual Fund (25.78%)
  • Others (1.44%)

SYNGENE Key Leadership Details

Last Updated: Mar 2026

NamePosition
Kiran Mazumdar ShawExecutive Chairman
Peter John BainsManaging Director & Chief Executive Officer
Catherine Patricia RosenbergNon Executive Independent Director

Syngene International Ltd Peer Comparison

CompanyPriceM.Cap (Cr)P/E (TTM)ROE (TTM)
Apollo Hospitals Enterprise LtdAPOLLOHOSP
8,696.50-0.20%
1,10,231.0759.0820.48%
Max Healthcare Institute LtdMAXHEALTH
1,025.00-0.49%
1,02,534.7972.2713.42%
Fortis Healthcare LtdFORTIS
870.30-1.11%
68,746.4970.1010.53%

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research